AJP - Endo Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (October 22, 2002). doi:10.1152/ajpendo.00382.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/2/E424    most recent
00382.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walgren, J. L
Right arrow Articles by Buse, M. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walgren, J. L
Right arrow Articles by Buse, M. G

Articles in PresS, published online ahead of print October 22, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00382.2002
Submitted on August 28, 2002
Accepted on October 16, 2002

High glucose/insulin promote O-GlcNAc modification of proteins including {alpha}-tubulin

Jennie L Walgren1, Timothy S Vincent2, Kevin L Schey3, and Maria G Buse4*

1 Department of Pharmacology, Medical University of South Carolina, Charleston, SC, USA; Department of Medicine, Division of Endocrinology, Diabetes, and Medical Genetics, Medical University of South Carolina, Charleston, SC, USA
2 Department of Pathology, Medical University of South Carolina, Charleston, SC, USA
3 Department of Pharmacology, Medical University of South Carolina, Charleston, SC, USA
4 Department of Medicine, Division of Endocrinology, Diabetes, and Medical Genetics, Medical University of South Carolina, Charleston, SC, USA; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA

* To whom correspondence should be addressed. E-mail: busemg{at}musc.edu.

Increased flux through the hexosamine biosynthesis pathway has been implicated in the development of glucose-induced insulin resistance and may promote the modification of certain proteins with O-linked GlcNAc. L6 myotubes (a model of skeletal muscle) were incubated for 18 hrs in 5 mM or 25 mM glucose ± 10 nM insulin. As assessed by immunoblotting with an O-GlcNAc-specific antibody, high glucose and/or insulin enhanced O-GlcNAcylation of numerous proteins, including the transcription factor Sp1, a known substrate for this modification. To identify novel proteins that may be O-GlcNAc-modified in a glucose concentration/insulin-responsive manner, total cell membranes were separated by 1D or 2D gel electrophoresis. Selected O-GlcNAcylated proteins were identified by mass spectrometry (MS) analysis. MS sequencing of tryptic peptides identified member(s) of the heat shock protein 70 (HSP70) family and rat {alpha}-tubulin. Immunoprecipitation/immunoblot studies demonstrated several HSP70 isoforms and/or post-translational modifications, some with selectively enhanced O-GlcNAcylation following exposure to high glucose + insulin. In conclusion, in L6 myotubes, Sp1, membrane-associated HSP70, and {alpha}-tubulin are O-GlcNAcylated; the modification is markedly enhanced by sustained increased glucose flux.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Hu, J. Suarez, E. Fricovsky, H. Wang, B. T. Scott, S. A. Trauger, W. Han, Y. Hu, M. O. Oyeleye, and W. H. Dillmann
Increased Enzymatic O-GlcNAcylation of Mitochondrial Proteins Impairs Mitochondrial Function in Cardiac Myocytes Exposed to High Glucose
J. Biol. Chem., January 2, 2009; 284(1): 547 - 555.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Laczy, B. G. Hill, K. Wang, A. J. Paterson, C. R. White, D. Xing, Y.-F. Chen, V. Darley-Usmar, S. Oparil, and J. C. Chatham
Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H13 - H28.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Guinez, A.-M. Mir, V. Dehennaut, R. Cacan, A. Harduin-Lepers, J.-C. Michalski, and T. Lefebvre
Protein ubiquitination is modulated by O-GlcNAc glycosylation
FASEB J, August 1, 2008; 22(8): 2901 - 2911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. J. Copeland, J. W. Bullen, and G. W. Hart
Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E17 - E28.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
N. Noach, Y. Segev, I. Levi, S. Segal, and E. Priel
Modification of Topoisomerase I Activity by Glucose and by O-Glcnacylation of the Enzyme Protein
Glycobiology, December 1, 2007; 17(12): 1357 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Fulop, Z. Zhang, R. B. Marchase, and J. C. Chatham
Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2227 - H2236.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. P. R. Rao, R. Wassell, M. A. Shaw, and K. Sharma
Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1182 - F1189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. Champattanachai, R. B. Marchase, and J. C. Chatham
Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C178 - C187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Bertrand, A. Ginion, C. Beauloye, A. D. Hebert, B. Guigas, L. Hue, and J.-L. Vanoverschelde
AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H239 - H250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Buse
Hexosamines, insulin resistance, and the complications of diabetes: current status
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Nagy, V. Champattanachai, R. B. Marchase, and J. C. Chatham
Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C57 - C65.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. T. Kneass and R. B. Marchase
Neutrophils Exhibit Rapid Agonist-induced Increases in Protein-associated O-GlcNAc
J. Biol. Chem., October 29, 2004; 279(44): 45759 - 45765.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. B. Arias, J. Kim, and G. D. Cartee
Prolonged Incubation in PUGNAc Results in Increased Protein O-Linked Glycosylation and Insulin Resistance in Rat Skeletal Muscle
Diabetes, April 1, 2004; 53(4): 921 - 930.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2002 by the American Physiological Society.